BRIEF published on 03/13/2025 at 13:23, 1 year ago Validation de l'acquisition de Galimmo par Carmila Cession Acquisition Immobilier Commercial CARMILA Autorité Concurrence
PRESS RELEASE published on 03/13/2025 at 13:18, 1 year ago Inside Information / Other news releases French Competition Authority approves Carmila's acquisition of Galimmo, Carmila to sell Villers Semeuse shopping gallery in 2025. No significant impact on financial targets Acquisition Competition Authority CARMILA Galimmo Villers Semeuse
PRESS RELEASE published on 03/13/2025 at 13:18, 1 year ago Informations privilégiées / Autres communiqués L'Autorité de la concurrence valide l'acquisition de Galimmo par Carmila. Carmila cèdera la galerie commerciale de Villers Semeuse en 2025 Cession Acquisition Autorité De La Concurrence CARMILA Galimmo
PRESS RELEASE published on 03/03/2025 at 15:48, 1 year ago Etats financiers 2024, commentaires et rapports des Commissaires aux comptes
BRIEF published on 03/03/2025 at 15:47, 1 year ago Carrefour Pro Dev affiche une croissance soutenue en 2024 Croissance Durable Green Bond Résultats Financiers 2024 Carrefour Pro Dev Acquisition Galimmo
BRIEF published on 03/03/2025 at 15:47, 1 year ago Carrefour Pro Dev shows sustained growth in 2024 Sustainable Growth Green Bond Financial Results 2024 Crossroads Pro Dev Galimmo Acquisition
PRESS RELEASE published on 03/03/2025 at 15:42, 1 year ago Communiqué de presse résultats 2024 Résultats annuels 2024 de Carmila : croissance soutenue grâce à l'acquisition de Galimmo et dynamique commerciale. Performance financière excellente, valeurs patrimoine en hausse, structure financière solide, émission d'un Green bond Croissance Résultats Annuels Green Bond CARMILA Galimmo
BRIEF published on 02/12/2025 at 19:07, 1 year 1 month ago Carmila lance un programme de rachat d'actions de 10 millions d'euros Rachat D'actions Euronext Paris Relations Avec Les Investisseurs CARMILA 10 Millions D'euros
BRIEF published on 02/12/2025 at 19:07, 1 year 1 month ago Carmila Initiates €10 Million Share Buyback Program Euronext Paris Share Buyback Investor Relations CARMILA €10 Million
PRESS RELEASE published on 02/12/2025 at 19:02, 1 year 1 month ago Informations privilégiées / Autres communiqués Carmila lance un programme de rachat d'actions pour 10 millions d'euros, avec une période d'achat allant du 13 février au 30 juin 2025. Les actions seront conservées en vue d'annulation future Rachat D'actions Assemblée Générale CARMILA Financier 10 Millions D'euros
Published on 03/26/2026 at 16:20, 2 hours 39 minutes ago ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 13:00, 5 hours 59 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 5 hours 59 minutes ago GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 6 hours ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 18:29, 29 minutes ago IEVA GROUP: IEVA Group is listing on Euronext Growth® Paris to accelerate its growth and innovation strategy
Published on 03/26/2026 at 18:29, 29 minutes ago IEVA GROUP: IEVA Group entre en bourse sur Euronext Growth pour accélérer sa stratégie de croissance et d’innovation
Published on 03/26/2026 at 18:13, 46 minutes ago EQS-Adhoc: Allgeier SE: Allgeier meets its earnings guidance for 2025 and is strengthening its focus on AI-based platform technologies and software solutions
Published on 03/26/2026 at 18:00, 59 minutes ago E-PANGO: E-Pango retrouve son statut de fournisseur électrique
Published on 03/26/2026 at 18:17, 42 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:00, 59 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 59 minutes ago LABORATOIRES EUROMEDIS - Fin du contrat de liquidité